The only remaining second-round ai awaiting a re-registration decision is the nematicide 1,3-dichloropropene, which should be reviewed this month.
The only remaining second-round ai awaiting a re-registration decision is the nematicide 1,3-dichloropropene, which should be reviewed this month.